Form 8-K - Current report:
SEC Accession No. 0001558370-16-004517
Filing Date
2016-04-05
Accepted
2016-04-05 11:45:35
Documents
3
Period of Report
2016-04-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvls-20160405x8k.htm 8-K 28566
2 EX-99.1 nvls-20160405ex9917235ad.htm EX-99.1 16993
3 GRAPHIC nvls20160405ex9917235ad001.jpg GRAPHIC 5430
  Complete submission text file 0001558370-16-004517.txt   54390
Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700
Nivalis Therapeutics, Inc. (Filer) CIK: 0001626199 (see all company filings)

EIN.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 161553460
SIC: 2834 Pharmaceutical Preparations